Drug Delivery Technology
BIOMAXX® technologies increase the solubility, permeability, and bioavailability of challenging compounds to improve drug performance
Many drugs do not advance through drug development or underperform in the market. The cause is often low bioavailability, which is primarily attributed to poor aqueous solubility and/or low permeability.
Kashiv has developed a broad range of proprietary technologies and extensive “know how” to maximize the bioavailability of poorly soluble and/or permeable drugs. More specifically, Kashiv has expertise in the areas of hot melt extrusion, spray drying, controlled precipitation, self-emulsifying micro/nano delivery systems, and bottom-up nano formulations with particle size of drug molecules as low as 50 nm to develop improved medicines with substantial medical utility.
The scientific expertise at Kashiv, gained at large research-based pharmaceutical companies, provides solutions ranging from improving current formulations, troubleshooting bioavailability issues, manufacturing supplies, and regulatory support for all phases of product development utilizing these complex dosage forms.
Key benefits associated with BIOMAXX® technology show that it:
• Enhances bioavailability
• Reduces pill burden
• Eliminates food effect
• Reduces drug variability
Other Drug Delivery Technology
We have developed several novel and proprietary technology platforms to significantly improve the efficacy, tolerability, and compliance of existing and new drugs.
An advanced osmotic oral drug delivery system for customizing timed drug release.
A novel gastric retention system that optimizes drug absorption and provides once daily dosing.
Long-acting injectable technologies to provide weeks to months of sustained drug delivery.